Skip to main content
Top
Published in: Clinical Rheumatology 11/2016

01-11-2016 | Brief Report

No impairment of pulmonary function in children with Henoch-Schonlein purpura after 4-year follow-up

Authors: Izabela Grabska-Kobylecka, Dariusz Nowak, Anna Wlodarczyk, Piotr Bialasiewicz

Published in: Clinical Rheumatology | Issue 11/2016

Login to get access

Abstract

Henoch-Schonlein purpura (HSP) is a generalized form of IgA-mediated vasculitis that usually spares pulmonary circulation. Nevertheless, it is conceivable that subclinical changes at the HSP onset may lead to lung impairment in the long term. Therefore, we decided to follow a group of HSP patients for 4 years to monitor changes in pulmonary function. A group of 11 children and adolescents diagnosed with HSP without apparent pulmonary involvement was subjected to pulmonary function tests (PFTs), i.e., spirometry, body plethysmography, and diffusing capacity for CO (DLCO); these tests were repeated after 48 months. No significant impairment was observed in variables of spirometry, body plethysmography, and DLCO expressed as % of predicted values (% predicted) after 4 years. Specifically, no significant change in DLCO, corrected for blood hemoglobin concentration was noted, i.e., 79.3 ± 10.1 vs. 81.6 ± 14.7 % predicted at the beginning and the end of the study, respectively. IgA vasculitis seems to spare pulmonary circulation as we found no impairment in PFTs within the study time frame and a median of almost 6 years from the first episode of the disease.
Literature
2.
go back to reference Nadrous HF, Yu AC, Specks U, Ryu JH (2004) Pulmonary involvement in Henoch-Schönlein purpura. Mayo Clin Proc 79:1151–1157PubMed Nadrous HF, Yu AC, Specks U, Ryu JH (2004) Pulmonary involvement in Henoch-Schönlein purpura. Mayo Clin Proc 79:1151–1157PubMed
3.
go back to reference Chaussain M, de Boissieu D, Kalifa G et al (1992) Impairment of lung diffusion capacity in Schönlein-Henoch purpura. J Pediatr 121:12–16CrossRefPubMed Chaussain M, de Boissieu D, Kalifa G et al (1992) Impairment of lung diffusion capacity in Schönlein-Henoch purpura. J Pediatr 121:12–16CrossRefPubMed
5.
go back to reference Epler G, McLoud T, Gaensler E, Mikus J, Carrington C (1978) Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 298:934–939CrossRefPubMed Epler G, McLoud T, Gaensler E, Mikus J, Carrington C (1978) Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 298:934–939CrossRefPubMed
6.
go back to reference Ozen S, Pistorio A, Iusan SM et al (2010) EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69:798–806. doi:10.1136/ard.2009.116657 CrossRefPubMed Ozen S, Pistorio A, Iusan SM et al (2010) EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69:798–806. doi:10.​1136/​ard.​2009.​116657 CrossRefPubMed
7.
go back to reference Cazzato S, Bernardi F, Cinti C et al (1999) Pulmonary function abnormalities in children with Henoch-Schönlein purpura. Eur Respir J 13:597–601CrossRefPubMed Cazzato S, Bernardi F, Cinti C et al (1999) Pulmonary function abnormalities in children with Henoch-Schönlein purpura. Eur Respir J 13:597–601CrossRefPubMed
Metadata
Title
No impairment of pulmonary function in children with Henoch-Schonlein purpura after 4-year follow-up
Authors
Izabela Grabska-Kobylecka
Dariusz Nowak
Anna Wlodarczyk
Piotr Bialasiewicz
Publication date
01-11-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 11/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3358-y

Other articles of this Issue 11/2016

Clinical Rheumatology 11/2016 Go to the issue